Ebastine

41 interactions 3 explained in plain English
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Dofetilide Buprenorphine Relugolix Glasdegib Foscarnet Injection Ketoconazole Topical
41 Major
All (41) Major (41)

Major

Ebastine Sertraline Explained An increased risk of QT interval prolongation Details Ebastine Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Ebastine Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Ebastine Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Ebastine Arsenic Trioxide Trisenox Increased risk of QT-interval prolongation and torsade de pointes Details Ebastine Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Ebastine Arsenic Trioxide Injection Trisenox Increased risk of QT-interval prolongation and torsade de pointes Details Ebastine Asenapine Transdermal Patch Secuado Increased risk of QT interval prolongation Details Ebastine Azithromycin AzaSite An increased risk of QT interval prolongation and torsade de pointes Details Ebastine Anagrelide Agrylin Increased risk of QT interval prolongation Details Ebastine Bedaquiline Sirturo Increased risk of QT interval prolongation Details Ebastine Chloroquine Aralen® Increased risk of QT-interval prolongation Details Ebastine Dasatinib Phyrago An increased risk of QT interval prolongation Details Ebastine Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Ebastine Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Ebastine Dofetilide Tikosyn An increased risk of QT interval prolongation Details Ebastine Encorafenib Braftovi Increased risk of QT interval prolongation Details Ebastine Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Ebastine Foscarnet Injection Foscavir Increased risk of QT interval prolongation Details Ebastine Fostemsavir Rukobia Increased risk of torsade de pointes Details Ebastine Glasdegib Daurismo Increased risk of QT interval prolongation Details Ebastine Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Ebastine Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Ebastine Hydroxychloroquine Plaquenil An increased risk of seizures and an increased risk of QT interval prolongation Details Ebastine Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation Details Ebastine Ivabradine Corlanor Increased risk of QT prolongation Details Ebastine Ketoconazole Topical Extina® Foam Increased risk of QT interval prolongation Details Ebastine Lefamulin Xenleta Increased risk of QT interval prolongation Details Ebastine Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Ebastine Levofloxacin Levaquin Increased risk of QT interval prolongation Details Ebastine Levofloxacin Injection Levaquin Increased risk of QT interval prolongation Details Ebastine Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Ebastine Metronidazole Flagyl An increased risk of QT interval prolongation Details Ebastine Metronidazole Injection Flagyl An increased risk of QT interval prolongation Details Ebastine Metronidazole Topical MetroCream® An increased risk of QT interval prolongation Details Ebastine Metronidazole Vaginal MetroGel® Vaginal An increased risk of QT interval prolongation Details Ebastine Moxifloxacin Avelox Increased risk of QT interval prolongation Details Ebastine Moxifloxacin Injection Avelox Increased risk of QT interval prolongation Details Ebastine Moxifloxacin Ophthalmic Moxeza® Increased risk of QT interval prolongation Details Ebastine Olodaterol Oral Inhalation Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.